ClearPoint Neuro, Inc.
CLPT
$14.90
$0.332.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.69% | -22.68% | -32.17% | -0.93% | 3.14% |
| Total Depreciation and Amortization | 31.86% | 8.51% | 76.53% | -31.95% | 87.43% |
| Total Amortization of Deferred Charges | 3.24% | 177.87% | 212.82% | 85.71% | -- |
| Total Other Non-Cash Items | 4.76% | 20.20% | -5.85% | -4.14% | 14.87% |
| Change in Net Operating Assets | 105.50% | 69.91% | -20,960.00% | -117.77% | 107.56% |
| Cash from Operations | 11.95% | 34.05% | -287.06% | -22.30% | 58.65% |
| Capital Expenditure | 66.82% | -1,216.33% | 75.38% | -118.68% | 50.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 66.82% | -159.28% | 646.73% | -118.68% | 50.27% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 576.35% | -54.60% | -- | -100.00% | 17,052.38% |
| Repurchase of Common Stock | 100.00% | -922.05% | -- | 100.00% | 72.72% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 200.00% |
| Cash from Financing | 154.25% | -109.43% | -- | -100.00% | 2,447.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.44% | -221.99% | 358.19% | -111.32% | 480.12% |